Published in Comp Biochem Physiol C on January 01, 1989
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert. J Nat Prod (2006) 1.20
Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155). Environ Health Perspect (1997) 1.00
Metabolism of zearalenone in the course of beer fermentation. Toxins (Basel) (2011) 0.84
Toxic effects of maternal zearalenone exposure on uterine capacity and fetal development in gestation rats. Reprod Sci (2013) 0.82
A new zearalenone biodegradation strategy using non-pathogenic Rhodococcus pyridinivorans K408 strain. PLoS One (2012) 0.82
A sensitive zonagenetic assay for rapid in vitro assessment of estrogenic potency of xenobiotics and mycotoxins. Environ Health Perspect (1999) 0.80
Individual in vitro effects of ochratoxin A, deoxynivalenol and zearalenone on oxidative stress and acetylcholinesterase in lymphocytes of broiler chickens. Springerplus (2014) 0.76
Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol (1999) 1.56
Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res (1998) 1.46
Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res (1985) 1.37
The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res (1999) 1.37
Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry (1990) 1.37
Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol (1987) 1.36
Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab (1997) 1.34
Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res (1999) 1.34
Expression of lumican in human breast carcinoma. Cancer Res (1998) 1.33
Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res (1999) 1.32
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res (1996) 1.31
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer (2006) 1.29
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor. Nature (1980) 1.29
Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res (1999) 1.23
Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol (2000) 1.21
Psoriasin (S100A7). Int J Biochem Cell Biol (1998) 1.20
Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol (1992) 1.18
Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol (2003) 1.17
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst (1984) 1.14
Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin. Biochem Biophys Res Commun (1994) 1.04
Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Cancer Res (1983) 1.02
Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol (1998) 1.02
Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens. Mol Cell Endocrinol (1982) 0.99
Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis (1992) 0.99
Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg (1999) 0.99
Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst (1996) 0.99
Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res (1984) 0.96
Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene. J Biol Chem (1984) 0.96
Environmental, management, and genetic factors affecting semen production in Holstein bulls. J Dairy Sci (1998) 0.95
Role of wild-type estrogen receptor-beta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells. Am J Physiol Endocrinol Metab (2008) 0.94
Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol (1999) 0.93
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Histopathology (2008) 0.93
Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res (1986) 0.90
Evidence of membrane changes during regression in the bovine corpus luteum. Endocrinology (1982) 0.89
Dietary lipids differentially affect membranes from different areas of rooster sperm. Poult Sci (2009) 0.89
Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site. J Clin Endocrinol Metab (1983) 0.88
The binding of tamoxifen to human mammary carcinoma cytosol. Eur J Cancer (1980) 0.88
Identification of differentially expressed genes using minute amounts of RNA. Biotechniques (1996) 0.87
Impact of genetic selection on management of boar replacement. Theriogenology (2005) 0.87
Biological actions of prolactin in human breast cancer. Recent Prog Horm Res (1987) 0.87
Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology (1987) 0.87
Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res (1998) 0.87
Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ (1990) 0.87
Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck (2001) 0.87
Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Res (1984) 0.87
The performance of gilts in a new group housing system: endocrinological and immunological functions. J Anim Sci (1992) 0.87
Spontaneous uptake of exogenous DNA by bull spermatozoa. Theriogenology (2005) 0.87
Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J Biol Chem (1998) 0.86
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol (1997) 0.85
A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor. J Endocrinol (1981) 0.85
Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res (1990) 0.85
A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion. Breast Cancer Res Treat (1997) 0.85
Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers. Cancer Res (2000) 0.85
Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro. Endocrinology (1985) 0.84
Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. J Cell Biochem (1996) 0.84
Effects of cold shock and phospholipase A2 on intact boar spermatozoa and sperm head plasma membranes. Mol Reprod Dev (1990) 0.84
Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene. J Cell Biochem (1996) 0.83
Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res (1996) 0.83
The knee-chest position does not improve the efficacy of ipecac-induced emesis. Am J Emerg Med (1989) 0.83
Effects of urea and trimethylamine N-oxide on fluidity of liposomes and membranes of an elasmobranch. Am J Physiol (1999) 0.82
Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts. J Steroid Biochem Mol Biol (1994) 0.82
Comparison of the trichothecenes deoxynivalenol and T-2 toxin for their effects on brain biogenic monoamines in the rat. Toxicol Lett (1988) 0.82
Functional characteristics of a novel murine estrogen receptor-beta isoform, estrogen receptor-beta 2. J Mol Endocrinol (2000) 0.81
Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res (1987) 0.81
Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues. Breast Cancer Res (2000) 0.80
Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells. Cell Growth Differ (1992) 0.80
Cryopreservation extenders affect calcium flux in bovine spermatozoa during a temperature challenge. J Androl (1995) 0.80
Phorbol esters differentially regulate the expression of insulin-like growth factor-binding proteins in endometrial carcinoma cells. Endocrinology (1992) 0.80
C-myc gene chromatin of estrogen receptor positive and negative breast cancer cells. Mol Cell Endocrinol (1993) 0.80
Modulation of postthaw motility, survival, calcium uptake, and fertility of bovine sperm by magnesium and manganese. J Dairy Sci (1996) 0.80
A new perspective on the mechanism of corpus luteum regression. Endocrinology (1979) 0.80
Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. J Clin Endocrinol Metab (1986) 0.80
Stress and dietary factors modify boar sperm for processing. Reprod Domest Anim (2011) 0.79
Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells. J Steroid Biochem Mol Biol (1991) 0.79
Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Cancer Res (1991) 0.79
Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun (1996) 0.79
Estrogen receptor diminishes DNA-binding activities of chicken GATA-1 and CACCC-binding proteins. DNA Cell Biol (1997) 0.79
Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines. J Steroid Biochem Mol Biol (1992) 0.78
Influence of estrogen receptor variants on the determination of ER status in human breast cancer. Breast Cancer Res Treat (1999) 0.78
Estrogen receptor beta: mine is longer than yours? J Clin Endocrinol Metab (1998) 0.78
Alterations in the cellular membranes of regressing rat corpora lutea. Endocrinology (1984) 0.78
Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues. Br J Cancer (1999) 0.78
Liquid storage of Asian elephant (Elephas maximus) sperm at 4 degrees C. Anim Reprod Sci (2004) 0.78
Growth factors in normal and malignant uterine tissue. Ann N Y Acad Sci (1991) 0.78
Relationship between maternal plasma progesterone concentration and interferon-tau synthesis by the conceptus in cattle. Theriogenology (1997) 0.78
Modifications in the aminoether side chain of clomiphene influence affinity for a specific antiestrogen binding site in MCF 7 cells cytosol. Biochem Biophys Res Commun (1981) 0.78
Cloning and characterization of chicken stromal cell derived factor-1. Dev Comp Immunol (2005) 0.78
Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases. Br J Cancer (1999) 0.78
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens. Breast Cancer Res Treat (1994) 0.78
Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer Res (1992) 0.78
Extender components and surfactants affect boar sperm function and membrane behavior during cryopreservation. J Androl (1999) 0.77
Responsiveness of porcine large and small luteal cells to luteotropic or luteolytic hormones and cell morphologic changes during the estrous cycle and pregnancy. J Anim Sci (1993) 0.77
Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells. J Mol Endocrinol (1999) 0.77
Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells. Mol Endocrinol (1992) 0.77
Plasma membrane changes during corpus luteum regression. Can J Physiol Pharmacol (1989) 0.77
Incorporating lipids into boar sperm decreases chilling sensitivity but not capacitation potential. Biol Reprod (2001) 0.77
Effect of insemination-ovulation interval and addition of seminal plasma on sow fertility to insemination of cryopreserved sperm. Reprod Domest Anim (2007) 0.76
Minimizing pectoralis myocutaneous flap loss with the delay principle. Otolaryngol Head Neck Surg (1996) 0.76
Compositional and physical properties of microsomal membrane lipids from regressing rat corpora lutea. Endocrinology (1981) 0.76